Vaccination of lambs with the recombinant protein rHc23 elicits significant protection against Haemonchus contortus challenge

- Recombinant protein (rHc23) from Haemonchus contortus has been cloned and expressed.
- Recombinant protein rHc23 has 203 aminoacids and a molecular mass of 24.15 kDa.
- rHc23 elicits a partial protection against H. contortus challenge in lambs.
- Vaccination with rHc23 induces > 80% reduction in epg counts and abomasal burdens.

Gene encoding a somatic protein of Haemonchus contortus (Hc23) known to confer significant protection against experimental haemonchosis has been cloned and expressed in a prokaryotic system. A cDNA library of H. contortus using the vector λ ZAP II was obtained. Full-length gene was amplified, cloned and expressed in Escherichia coli BL21. The recombinant protein was purified in Ni-NTA column. Recombinant protein (rHc23) had 203 aminoacids and a molecular mass of 24.15 kDa. Recombinant protein (100 μg/dose) with aluminum hydroxide as adjuvant was administered to 5-6 months age female Assaf lambs on days −42, −28 and −14. On day 0 animals were infected with 15,000 L3 of H. contortus. Vaccination with rHc23 elicited a significant protection against challenge, with > 80% reductions in both fecal egg counts and average abomasal parasite burdens at the end of the experiment (45 days post challenge) besides lack of variations in packed cell volume. Results support the feasibility of vaccination against lamb haemonchosis with a recombinant product from an exposed antigen.